| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 4 | |
| #2 | Tunisia | 3 | |
| #3 | Canada | 2 | |
| #4 | Japan | 2 | |
| #5 | Brazil | 1 | |
| #6 | China | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | Mexico | 1 | |
| #10 | Norway | 1 | |
| #11 | New Zealand | 1 | |
| #12 | Singapore | 1 | |
| #13 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Micro-structure and nano-technology | |
| #5 | Machines |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yatscoff Randall W | 10 |
| #2 | Foster Robert T | 10 |
| #3 | Sugiyama Shin | 9 |
| #4 | Trepanier Dan J | 9 |
| #5 | Fenske Bruce W | 9 |
| #6 | Hegmans Alexander | 9 |
| #7 | Abel Mark D | 9 |
| #8 | Naicker Selvaraj | 8 |
| #9 | Ure Daren R | 5 |
| #10 | Abel Mark | 4 |
| Publication | Filing date | Title |
|---|---|---|
| BR112013014890A2 | compound, pharmaceutical composition, method for the treatment or prevention of cyclophilin-mediated diseases, process for the preparation of a compound, use of the compound | |
| EP2307446A1 | Nonimmunosuppressive cyclosporine analogue molecules | |
| AU2007221839A1 | Synthesis of cyclosporin analogs | |
| AU2004218637A1 | Deuterated cyclosporin analogs and their use as immunomodulating agents |